Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Public health impact of the COVID-19 pandemic on the emergency healthcare system.
Stirparo G, Oradini-Alacreu A, Migliori M, Villa GF, Botteri M, Fagoni N, Signorelli C, Sechi GM, Zoli A. Stirparo G, et al. Among authors: zoli a. J Public Health (Oxf). 2022 Mar 7;44(1):e149-e152. doi: 10.1093/pubmed/fdab212. J Public Health (Oxf). 2022. PMID: 34156071 Free PMC article.
Missed training, collateral damage from COVID 19?
Giuseppe S, Bellini L, Fagoni N, Compatti S, Botteri M, Villa GF, Sironi S, Signorelli C, Sechi GM, Zoli A. Giuseppe S, et al. Among authors: zoli a. Disaster Med Public Health Prep. 2022 Jan 10:1-8. doi: 10.1017/dmp.2022.14. Online ahead of print. Disaster Med Public Health Prep. 2022. PMID: 35000651 Free PMC article.
Pregnancy in Autoimmune Hypophysitis: Management of a Rare Condition.
Costanza F, Cicia M, Giampietro A, Tartaglione T, Angelini F, Zoli A, Ferrazzani S, De Marinis L, Pontecorvi A, Bianchi A, Chiloiro S. Costanza F, et al. Among authors: zoli a. Endocr Metab Immune Disord Drug Targets. 2024 Jul 30. doi: 10.2174/0118715303314953240719044233. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 39082174
Bispecific T cell engager therapy for refractory rheumatoid arthritis.
Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, Wacker J, Wilhelm A, Auger JP, Pachowsky M, Eckstein M, Alivernini S, Zoli A, Krönke G, Uderhardt S, Bozec A, D'Agostino MA, Schett G, Grieshaber-Bouyer R. Bucci L, et al. Among authors: zoli a. Nat Med. 2024 Jun;30(6):1593-1601. doi: 10.1038/s41591-024-02964-1. Epub 2024 Apr 26. Nat Med. 2024. PMID: 38671240
241 results